Your session is about to expire
← Back to Search
Study Summary
This trial is testing whether a laser can effectively and safely treat acne vulgaris.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with mild to almost clear acne on one side of my face.I have had radiation or am being treated for skin cancer or receiving chemotherapy.I haven't had any treatments on the target area in the last month.I haven't been part of a clinical trial for a drug or device targeting the same area in the last month.I have been diagnosed with a pigment disorder in the area of interest.I agree to limit my sun exposure and use SPF 30+ sunscreen daily during the study.I agree not to have any other treatments in the target area during the study.People with any type of skin color can participate.I haven't had injections like collagen in the target area within the last 2 weeks.I haven't taken any retinoid medication like isotretinoin in the last 6 months.I have a blood clotting disorder or am on blood thinners.I have an immune system disorder or am taking medication that weakens my immune system.I do not have excessive facial hair or adornments that could interfere with treatment on my face.I have moderate to severe acne on both sides of my face.I do not have skin conditions in the acne area that could affect its assessment.I am between 16 and 50 years old.I haven't had botulinum toxin injections in the target area within the last month and won't during the study.I can follow the treatment plan and care instructions.I have had cancer in the area being targeted for treatment.I am taking medication that makes my skin more sensitive to light.You have had a bad reaction to Pro-Nox or a similar medication in the past.You have a history of a condition in the target area that gets worse with heat, unless you are taking preventive treatment.I am willing to stop using acne treatments on my face for 2 weeks and any oral acne medication for 1 month before the study starts.I have been diagnosed with a connective tissue disease.
- Group 1: 1726nm Laser Treatment
- Group 2: Sham Laser Treatment
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an opportunity for me to join this experiment?
"This clinical trial seeks 30 individuals aged between 16 and 50 who are afflicted with acne vulgaris. In order to qualify, candidates must be of either gender within the specified age range (inclusive), have a Fitzpatrick Skin Type I-VI, possess moderate to severe inflammatory lesions as assessed by an expert examiner via their Global Assessment Scale, understand English in terms of reading, speaking, and signing documents such as informed consent forms; abstain from topical skincare products for two weeks prior to baseline testing and systemic medications for one month before beginning treatment; adhere strictly to follow up schedules while limiting sun exposure and wearing SPF 30 or above sunscreen daily"
Is there an age limit to enrolling in this experiment?
"In line with the requirements of this trial, only individuals between sixteen and fifty years old are eligible for inclusion."
Is this medical experiment currently accepting participants?
"The information on clinicaltrials.gov indicates that this trial is actively recruiting participants, having been first published on the 27th of July 2022 and receiving its most recent update a few months later."
How many people have been recruited to participate in this research endeavor?
"Affirmative. According to information displayed on clinicaltrials.gov, this experiment is currently recruiting participants and was first made public on July 27th 2022. It has been recently edited as of September 30th 2022 and requires the recruitment of 30 patients across 3 sites."
Who else is applying?
How old are they?
What portion of applicants met pre-screening criteria?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger